TXNDC9 Antikörper (AA 182-226) (FITC)
-
- Target Alle TXNDC9 Antikörper anzeigen
- TXNDC9 (Thioredoxin Domain Containing 9 (TXNDC9))
-
Bindungsspezifität
- AA 182-226
-
Reaktivität
- Human, Maus, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser TXNDC9 Antikörper ist konjugiert mit FITC
-
Applikation
- Western Blotting (WB), Immunofluorescence (Paraffin-embedded Sections) (IF (p))
- Kreuzreaktivität
- Human, Maus, Ratte
- Aufreinigung
- Purified by Protein A.
- Immunogen
- KLH conjugated synthetic peptide derived from human TXNDC9
- Isotyp
- IgG
- Top Product
- Discover our top product TXNDC9 Primärantikörper
-
anti-Thioredoxin Domain Containing 9 (TXNDC9) (AA 1-226) antibody
TXNDC9 Reaktivität: Human WB, ELISA, IF Wirt: Maus Monoclonal 1E8-7C12 unconjugated
anti-Thioredoxin Domain Containing 9 (TXNDC9) (AA 182-226) antibodyTXNDC9 Reaktivität: Human, Maus, Ratte WB, IF (p), IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Thioredoxin Domain Containing 9 (TXNDC9) (AA 1-188) antibodyTXNDC9 Reaktivität: Human WB, IP Wirt: Kaninchen Polyclonal unconjugated
anti-Thioredoxin Domain Containing 9 (TXNDC9) (AA 1-188) antibodyTXNDC9 Reaktivität: Human WB, IF Wirt: Maus Polyclonal unconjugated
anti-Thioredoxin Domain Containing 9 (TXNDC9) (AA 1-110) antibodyTXNDC9 Reaktivität: Human WB, IF, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Thioredoxin Domain Containing 9 (TXNDC9) (AA 1-188) antibodyTXNDC9 Reaktivität: Human ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- IF(IHC-P) 1:50-200
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 μg/μL
- Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
- Haltbarkeit
- 12 months
-
- Target
- TXNDC9 (Thioredoxin Domain Containing 9 (TXNDC9))
- Andere Bezeichnung
- TXNDC9 (TXNDC9 Produkte)
- Synonyme
- fb15e07 antikoerper, zgc:55522 antikoerper, wu:fb15e07 antikoerper, apacd antikoerper, TXNDC9 antikoerper, MGC147198 antikoerper, DKFZp468L2419 antikoerper, APACD antikoerper, PHLP3 antikoerper, AI098020 antikoerper, thioredoxin domain containing 9 antikoerper, thioredoxin domain containing 9 L homeolog antikoerper, TXNDC9 antikoerper, txndc9 antikoerper, txndc9.L antikoerper, Txndc9 antikoerper
- Hintergrund
-
Synonyms: APACD, PHLP3, Thioredoxin domain-containing protein 9, ATP-binding protein associated with cell differentiation, Protein 1-4, TXNDC9
Background: Significantly diminishes the chaperonin TCP1 complex ATPase activity, thus negatively impacts protein folding, including that of actin or tubulin.
- Gen-ID
- 10190
- UniProt
- O14530
- Pathways
- Cell RedoxHomeostasis
-
